gvs 111 has been researched along with 2-amino-5-phosphonovalerate in 1 studies
| Studies (gvs 111) | Trials (gvs 111) | Recent Studies (post-2010) (gvs 111) | Studies (2-amino-5-phosphonovalerate) | Trials (2-amino-5-phosphonovalerate) | Recent Studies (post-2010) (2-amino-5-phosphonovalerate) |
|---|---|---|---|---|---|
| 91 | 2 | 31 | 4,393 | 1 | 539 |
| Protein | Taxonomy | gvs 111 (IC50) | 2-amino-5-phosphonovalerate (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeva, NA; Gudasheva, TA; Isaev, NK; Ostrovskaya, RU; Stel'mashuk, EV; Viktorov, IV | 1 |
1 other study(ies) available for gvs 111 and 2-amino-5-phosphonovalerate
| Article | Year |
|---|---|
Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain Ischemia; Cells, Cultured; Cerebellum; Dipeptides; Glucose; Glutamic Acid; Neurons; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Oxygen; Piracetam; Rats; Rats, Wistar | 2000 |